Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 safety and pharmacokinetics of ONO-1110 in healthy Japanese adult males
jRCT2071220100Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ONO-1110 (5 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Safety and tolerability of ONO-1110 (all parts), Pharmacokinetic profile of ONO-1110 (all parts) and 1 more. Started Feb 2023; status: completed.
02
Drugs
ONO-1110
Beyond the preview
Go deeper on jRCT2071220100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220100.